Management of Elevated LDL and Non-HDL Cholesterol

Risk Stratification and Treatment Goals

The American College of Cardiology recommends that patients with an LDL cholesterol of 138 mg/dL or higher should have a primary goal of <100 mg/dL, and for those with established vascular disease or high cardiovascular risk, intensify LDL-lowering therapy with a statin or bile acid resin, combined with aggressive therapeutic lifestyle changes 1, 2, 3
The American Heart Association suggests that a non-HDL cholesterol of 150 mg/dL exceeds the secondary goal of <130 mg/dL, which becomes relevant when triglycerides are ≥200 mg/dL, and recommends intensifying LDL-lowering therapy with a statin or bile acid resin, combined with aggressive therapeutic lifestyle changes 1, 2, 3

The American College of Cardiology recommends initiating or intensifying statin therapy for LDL ≥130 mg/dL, with a moderate-to-high intensity statin to achieve the target LDL <100 mg/dL, and increasing the dose or switching to a more potent agent if the patient is already on a statin 1, 2
The National Lipid Association suggests implementing therapeutic lifestyle changes concurrently, including dietary therapy with <7% saturated fat and <200 mg/day cholesterol, physical activity, and weight management 1, 2, 3

The American Heart Association recommends reducing saturated fat to <7% of total calories, limiting dietary cholesterol to <200 mg/day, adding plant stanols/sterols (2 g/day) and viscous fiber (10-25 g/day), and increasing consumption of omega-3 fatty acids 1, 2, 3
The National Lipid Association suggests a minimum of 30-60 minutes of moderate-intensity activity, preferably daily, or at least 3-4 times weekly, and targeting a BMI range of 18.5-24.9 kg/m², with a 10% weight reduction in the first year if BMI ≥25 kg/m² 1, 2, 3

The American College of Cardiology recommends reassessing lipid profile after 6 weeks of initiating or intensifying statin therapy, and continuing reassessment every 6 weeks during dose titration until LDL goal is achieved, then measuring lipid levels annually once LDL is stabilized at goal 4

The American Heart Association suggests that if triglycerides are 200-499 mg/dL, consider adding fibrate or niacin after achieving LDL goal, and that achieving LDL <100 mg/dL with statin therapy will simultaneously lower non-HDL cholesterol 1, 2, 3

The American College of Cardiology expects statin therapy to achieve at least a 30-40% reduction in LDL cholesterol, and therapeutic lifestyle changes to contribute an additional 15-25 mg/dL reduction 4, 5